- Home
- AIIO vs BVS Comparison
AIIO vs BVS Comparison
Compare AIIO & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIIO
- BVS
- Stock Information
- Founded
- AIIO N/A
- BVS 2011
- Country
- AIIO United Arab Emirates
- BVS United States
- Employees
- AIIO N/A
- BVS N/A
- Industry
- AIIO Auto Manufacturing
- BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- AIIO Industrials
- BVS Health Care
- Exchange
- AIIO Nasdaq
- BVS Nasdaq
- Market Cap
- AIIO 468.5M
- BVS 476.3M
- IPO Year
- AIIO N/A
- BVS 2021
- Fundamental
- Price
- AIIO $0.56
- BVS $7.08
- Analyst Decision
- AIIO
- BVS Strong Buy
- Analyst Count
- AIIO 0
- BVS 4
- Target Price
- AIIO N/A
- BVS $13.75
- AVG Volume (30 Days)
- AIIO 5.7M
- BVS 368.6K
- Earning Date
- AIIO 05-27-2026
- BVS 11-04-2025
- Dividend Yield
- AIIO N/A
- BVS N/A
- EPS Growth
- AIIO N/A
- BVS N/A
- EPS
- AIIO N/A
- BVS 0.15
- Revenue
- AIIO $5,742,000.00
- BVS $563,829,000.00
- Revenue This Year
- AIIO N/A
- BVS N/A
- Revenue Next Year
- AIIO N/A
- BVS $7.22
- P/E Ratio
- AIIO N/A
- BVS $46.07
- Revenue Growth
- AIIO N/A
- BVS 1.58
- 52 Week Low
- AIIO $0.30
- BVS $5.81
- 52 Week High
- AIIO $3.48
- BVS $12.61
- Technical
- Relative Strength Index (RSI)
- AIIO 35.30
- BVS 47.71
- Support Level
- AIIO $0.51
- BVS $7.43
- Resistance Level
- AIIO $0.73
- BVS $7.79
- Average True Range (ATR)
- AIIO 0.12
- BVS 0.35
- MACD
- AIIO 0.02
- BVS 0.01
- Stochastic Oscillator
- AIIO 26.84
- BVS 31.79
About AIIO Robo.ai Inc. Class B Ordinary Shares
Robo.ai Inc is a pioneering smart electric vehicle company which aims to integrate avant-garde design, life-style personalization, IoT connectivity, and autonomous driving technology into a passenger-centric green premium mobility solution to the world. Geographically, the company operates in The United States, The United Arab Emirates, Mainland China.
About BVS Bioventus Inc.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.